PA, C., G, G., C, C., SL, G., E, H., M, H., . . . MA, P. (2007). The incidence and significance of anti-natalizumab antibodies: Results from AFFIRM and SENTINEL. Neurology, 69(14), 1391. https://doi.org/10.1212/01.wnl.0000277457.17420.b5
Chicago Style (17th ed.) CitationPA, Calabresi, et al. "The Incidence and Significance of Anti-natalizumab Antibodies: Results from AFFIRM and SENTINEL." Neurology 69, no. 14 (2007): 1391. https://doi.org/10.1212/01.wnl.0000277457.17420.b5.
MLA (9th ed.) CitationPA, Calabresi, et al. "The Incidence and Significance of Anti-natalizumab Antibodies: Results from AFFIRM and SENTINEL." Neurology, vol. 69, no. 14, 2007, p. 1391, https://doi.org/10.1212/01.wnl.0000277457.17420.b5.
Warning: These citations may not always be 100% accurate.